Actinogen Medical LimitedASX: ACW

ACW webinar today, The future of Alzheimers treatment

· Issued by Actinogen Medical Limited via ASX

Filed with ASX · · 18 pages · English

Summary by 6ix AI

Actinogen Medical Limited has announced a webinar titled 'The future of Alzheimer’s disease treatment' scheduled for today, which aims to provide insights into evolving diagnostic and therapeutic approaches for Alzheimer's disease. The webinar will feature discussions moderated by the Chief Commercial Officer and include expert perspectives from a renowned neurologist and the Chief Medical Officer of Actinogen. This event is intended for investors and stakeholders to understand the current landscape of Alzheimer's treatment and the potential impact of new therapies.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Actinogen Medical Limited ACN 086 778 476 Suite 901, Level 9, 109 Pitt Street, Syd n ey NSW 2000 +61 2 8964 7401 | actinogen.com.au 1 ASX ANNOUNCEMENT ACW Clinical Trials Science Forum webinar today – The future of Alzheimer’s disease treatment Sydney, 12 August 2026....

Actinogen Medical Limited on 6ix

Story so far

Earlier from Actinogen Medical

Later from Actinogen Medical

All Actinogen Medical news releases